Mechanistically, HECTD2 functions as an E3 ubiquitin ligase to facilitate the ubiquitination of The Kelch‐like ECH‐associated protein 1 (KEAP1), leading to the activation of the antioxidative response and limiting the sensitivity of HCC cells to lenvatinib. The gene discussed is HECTD2; the disease is hepatocellular carcinoma.